SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Smruthi Orgnics informs about receipt of attestation of inspection

04 Mar 2026 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Smruthi Orgnics has informed that the company has received an ‘Attestation of Inspection’ from the European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, following the inspection conducted at its flagship API manufacturing facility, Unit II, Solapur, Maharashtra from 27 August 2025 to 29 August 2025. The attestation confirms compliance with the applicable European Good Manufacturing Practice (EU GMP) requirements under the CEP framework in respect of Amlodipine Besilate. A detailed disclosure in this regard is enclosed.

The above information is a part of company’s filings submitted to BSE.


Smruthi Organics Share Price

112.94 -2.15 (-1.87%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×